Document Detail

Neuromodulation for neurodegenerative conditions .
MedLine Citation:
PMID:  23277004     Owner:  NLM     Status:  In-Data-Review    
Pharmacological therapy has had limited success in the treatment of most major neurological diseases. This has motivated the development of a number of novel surgical approaches designed to ameliorate drug-induced side effects or pharmacoresistant symptoms. Deep brain stimulation (DBS) has been quite successful in controlling both the cardinal motor manifestation of Parkinson's disease and the side effects of prolonged levodopa therapy. This has encouraged the application of DBS technology to treat a number of other neurodegenerative conditions, including secondary dystonia associated with pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome), chorea associated with Huntington's disease, and most recently, cognitive decline associated with Alzheimer's type dementia. We review the rationale, indications and outcomes of neuromodulation for selected neurodegenerative conditions. In addition to DBS, we discuss select small molecule and gene-based neuromodulatory approaches. Ongoing study of basic pathophysiological mechanisms may eventually allow directed primary prevention of some of these diseases, but until then, invasive neuromoduation will likely continue to play an ever-increasing role in the delivery of the most advanced care for patients with these debilitating conditions.
Travis S Tierney; Viren S Vasudeva; Sharada Weir; Michael T Hayes
Related Documents :
24315954 - Gpr120 agonism as a countermeasure against metabolic diseases.
23115014 - Explaining freezing of gait in parkinson's disease: motor and cognitive determinants.
24168084 - Surveillance for creutzfeldt-jakob disease in australia: update to december 2012.
22997874 - Neurodegenerative diseases.
23428644 - High-density lipoprotein subfractions--what the clinicians need to know.
18052874 - Chloroquine has not disappeared.
Publication Detail:
Type:  Journal Article     Date:  2013-01-01
Journal Detail:
Title:  Frontiers in bioscience (Elite edition)     Volume:  5     ISSN:  1945-0508     ISO Abbreviation:  Front Biosci (Elite Ed)     Publication Date:  2013  
Date Detail:
Created Date:  2013-01-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101485240     Medline TA:  Front Biosci (Elite Ed)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  490-9     Citation Subset:  IM    
Brigham and Women's Hospital, Department of Neurosurgery, 75 Francis Street, Boston, MA, 02115.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Histogenetic aspects of deer antler development .
Next Document:  (Pro)renin receptor: subcellular localizations and functions .